VEGF 3D Structures
From Proteopedia
(Difference between revisions)
Line 6: | Line 6: | ||
*VEGF-A; Domains - receptor-binding domain 27-135 (RBD); heparin-binding domain 137-191 | *VEGF-A; Domains - receptor-binding domain 27-135 (RBD); heparin-binding domain 137-191 | ||
- | **[[1bj1]], [[2fjg]], [[2fjh]], [[2qr0]], [[3bdy]] - hVEGF-A RBD + antibody – human<br /> | + | **[[1bj1]], [[2fjg]], [[2fjh]], [[2qr0]], [[3bdy]], [[5o4e]], [[7kez]], [[7kf0]] - hVEGF-A RBD + antibody – human<br /> |
**[[4kzn]], [[3qtk]], [[2vpf]], [[1vpf]] - hVEGF-A RBD<br /> | **[[4kzn]], [[3qtk]], [[2vpf]], [[1vpf]] - hVEGF-A RBD<br /> | ||
**[[3p9w ]]- hVEGF-A + hFab heavy chain<br /> | **[[3p9w ]]- hVEGF-A + hFab heavy chain<br /> | ||
**[[5fv1]], [[5fv2]] – hVEGF-A RBD + antibody residues 1-108<br /> | **[[5fv1]], [[5fv2]] – hVEGF-A RBD + antibody residues 1-108<br /> | ||
**[[6zfl]] - hVEGF-A residues 217-315 <br /> | **[[6zfl]] - hVEGF-A residues 217-315 <br /> | ||
- | **[[4zff]] - hVEGF-A residues 217-315 + antibody<br /> | + | **[[4zff]], [[6bft]], [[7kf1]] - hVEGF-A residues 217-315 + antibody<br /> |
**[[1tzh]], [[1tzi]] [[1cz8]] - hVEGF-A + antibody - mouse<br /> | **[[1tzh]], [[1tzi]] [[1cz8]] - hVEGF-A + antibody - mouse<br /> | ||
**[[1mkg]], [[1mkk]], [[1mjv]] – hVEGF-A (mutant) <br /> | **[[1mkg]], [[1mkk]], [[1mjv]] – hVEGF-A (mutant) <br /> | ||
Line 18: | Line 18: | ||
**[[1vgh]], [[2vgh]] - hVEGF-A heparin-binding domain - NMR<br /> | **[[1vgh]], [[2vgh]] - hVEGF-A heparin-binding domain - NMR<br /> | ||
**[[1qty]], [[1flt]] – hVEGF-A RBD + hFMS-like tyrosine <br /> | **[[1qty]], [[1flt]] – hVEGF-A RBD + hFMS-like tyrosine <br /> | ||
- | **[[6v7k]], [[6z13]], [[6z3f]], [[6zbr]], [[6zcd]] - hVEGF-A RBD + peptide <br /> | + | **[[6d3o]], [[6v7k]], [[6z13]], [[6z3f]], [[6zbr]], [[6zcd]] - hVEGF-A RBD + peptide <br /> |
**[[1vpp]] – hVEGF-A + receptor blocking peptide <br /> | **[[1vpp]] – hVEGF-A + receptor blocking peptide <br /> | ||
**[[1kat]] - hVEGF-A RBD + peptide antagonist – NMR<br /> | **[[1kat]] - hVEGF-A RBD + peptide antagonist – NMR<br /> | ||
Line 30: | Line 30: | ||
**[[4wpb]] – hVEGF-A + a/bVEGF<br /> | **[[4wpb]] – hVEGF-A + a/bVEGF<br /> | ||
**[[5hhc]], [[5hhd]] – hVEGF-A heterochiral<br /> | **[[5hhc]], [[5hhd]] – hVEGF-A heterochiral<br /> | ||
+ | **[[5t89]] - hVEGF-A RBD + VEGFR1<br /> | ||
*VEGF-B | *VEGF-B |
Current revision
3D Structures of VEGF
Updated on 18-March-2024 - For a general description of the protein see Vascular Endothelial Growth Factor